Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Study Title
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
Teva Identifier
DR-103-301
ClinicalTrials.gov Identifier
NCT00996580
Study Status
Completed
Trial Condition(s)
Pregnancy Prevention
Interventions
Drug: DR-103

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age Range
18 Years to 40 Years
Trial Duration
10/01/2009 - 09/01/2011
Phase
Phase 3

Study Type

Interventional